Our Company

1-2 of 2

Analysis of second- and third-line antihypertensive treatments after initial therapy with an angiotensin II receptor blocker using real-world Japanese data01 August 2016 - By Kosuke Iwasaki and Mitsuru Ohishi and Shinzo Hiroi and Takashi Kikuchi and Yujiro Otsuka and Yukio Shimasaki - Article

This study examines combination therapies administered following initial therapy with an angiotensin II receptor blocker in hyperintensive Japanese patients.

Current treatment status and medical cost for multiple sclerosis based on analysis of a Japanese claims database04 April 2016 - By Hiroyuki Ohta and Izumi Kawachi and Kazuyoshi Otake and Kosuke Iwasaki and Mieko Ogino and Shinzo Hiroi and Yujiro Otsuka - Article

This study provides up-to-date information on the demographics, medical treatment and cost status of multiple sclerosis treatment in Japan in almost real-time by using a claims database.


  • Work at Milliman

    • “I was offered a chance to come in, shake things up, create something."
    Work at Milliman